This association may arise from multiple genetic mechanisms: in chromosomal disorders, exemplified by trisomy 21, the dosage effects of genes such as DYRK1A can directly affect skeletal development, while concomitant structural or functional cardiac abnormalities may further limit the child’s growth potential [21,22]. This evidence concerns the gene DYRK1A and chromosomal disorder.